On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screening

被引:1
|
作者
Tatar, Ovidiu [1 ,2 ]
Haward, Ben [1 ,3 ,4 ]
Perez, Samara [5 ,6 ,7 ,8 ]
Zhu, Patricia [1 ]
Brotherton, Julia [9 ]
Decker, Kathleen [10 ,11 ]
Lofters, Aisha K. [12 ,13 ]
Mayrand, Marie-Helene [14 ]
Mcbride, Emily [14 ]
Ogilvie, Gina [15 ,16 ,17 ,18 ]
Shapiro, Gilla K. [18 ,19 ]
Smith, Laurie W. [15 ,16 ,17 ,18 ]
Steben, Marc [7 ,20 ]
Waller, Jo [19 ,21 ,22 ]
Zimet, Gregory D. [20 ]
Rosberger, Zeev [1 ,6 ,7 ,15 ,21 ,22 ,23 ,24 ]
机构
[1] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Chemin Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada
[2] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada
[3] Harvard Univ, Harvard Law Sch, Cambridge, MA 02138 USA
[4] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02115 USA
[5] McGill Univ Hlth Ctr, Cedars Canc Ctr, Psychosocial Oncol Program, Div Support & Palliat Care, Montreal, PQ, Canada
[6] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada
[7] HPV Global Act, Montreal, PQ, Canada
[8] Res Inst McGill Univ Hlth Ctr, Montreal, PQ, Canada
[9] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Australia
[10] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada
[11] Canc Care Manitoba, Paul Albrechtsen Res Inst, Winnipeg, MB, Canada
[12] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[13] Womens Coll Hosp, Dept Family & Community Med, Toronto, ON, Canada
[14] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada
[15] Kingss Coll London, Inst Psychiat Psychol & Neurosci, London, England
[16] BC Ctr Dis Control, Vancouver, BC, Canada
[17] Univ British Columbia, Fac Med, Vancouver, BC, Canada
[18] Women Hlth Res Inst, Vancouver, BC, Canada
[19] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[20] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada
[21] Queen Mary Univ London, Wolfson Inst Populat Hlth, London, England
[22] Indiana Univ, Emeritus Sch Med, Indianapolis, IN USA
[23] McGill Univ, Dept Psychiat, Montreal, PQ, Canada
[24] McGill Univ, Dept Psychol, Montreal, PQ, Canada
来源
基金
加拿大健康研究院;
关键词
Cervical screening; HPV testing; Self-sampling; Attitudes and beliefs; Screening intentions; Obstetrics and gynecology; Public health; Reproductive health; Women's health; Human papillomavirus; Cancer prevention; Behavioural sciences; FOLLOW-UP; KNOWLEDGE; ATTITUDES; ONTARIO; SAMPLE; COHORT;
D O I
10.1016/j.lana.2024.100901
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background HPV test-based primary cervical screening is replacing cytology in Canada. In other countries, women's unpreparedness and concerns hindered the transition and post-implementation screening uptake. We investigated psychosocial correlates of intentions of screening in eligible individuals to participate in HPV-based primary cervical screening. Methods We conducted a nationwide web-based survey of individuals aged 21-70 years in 2022 and oversampled under-screened individuals. We used five Canadian-validated scales to measure HPV test-based screening knowledge, attitudes, and beliefs. Using the multistage Precaution Adoption Process Model, we assessed women's stage of intentions to participate in HPV testing and self-sampling. We estimated associations of psychosocial factors with intentions' stage using multinomial logistic regression. Findings In both groups (adequately screened n = 1778; under-screened n = 1570), higher HPV knowledge was associated with intention for HPV testing and more personal barriers to the HPV test were associated with lower intentions to participate in HPV testing or use of self-sampling. In both groups, higher self-sampling concerns were associated with lower intentions for self-sampling and higher women's need for autonomy was associated with increased intentions for self-sampling. In the under-screened group, increased age was associated with lower intentions for HPV testing and self-sampling, while living in Canada for <10 years was associated with higher intentions. Interpretation Our results could be used by policymakers and healthcare professionals to design communication strategies and ensure a smooth transition to HPV-based primary cervical screening, especially for under-screened individuals. FundingCanadian Institutes of Health Research project grant 165905.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
    Fujita, Misuzu
    Nagashima, Kengo
    Shimazu, Minobu
    Suzuki, Misae
    Tauchi, Ichiro
    Sakuma, Miwa
    Yamamoto, Setsuko
    Hanaoka, Hideki
    Shozu, Makio
    Tsuruoka, Nobuhide
    Kasai, Tokuzo
    Hata, Akira
    PLOS ONE, 2023, 18 (06):
  • [42] Randomised controlled trial of the effect of evidence based information on women's willingness to participate in cervical cancer screening
    Adab, P
    Marshall, T
    Rouse, A
    Randhawa, B
    Sangha, H
    Bhangoo, N
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2003, 57 (08) : 589 - 593
  • [43] Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women, 1990-1998
    Petry, KU
    Böhmer, G
    Iftner, T
    Flemming, P
    Stoll, M
    Schmidt, RE
    GYNECOLOGIC ONCOLOGY, 1999, 75 (03) : 427 - 431
  • [44] Randomized Implementation of a Primary Human Papillomavirus Testing-based Cervical Cancer Screening Protocol for Women 34 to 69 Years in Norway
    Nyga, Mari
    Engesaeter, Birgit
    Castle, Philip E.
    Berland, Jannicke Mohr
    Eide, Maj Liv
    Iversen, Ole Erik
    Jonassen, Christine Monceyron
    Christiansen, Irene Kraus
    Vintermyr, Olav Karsten
    Trope, Ameli
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (09) : 1812 - 1822
  • [45] Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study
    Zorzi, M.
    Del Mistro, A.
    Farruggio, A.
    de' Bartolomeis, L.
    Frayle-Salamanca, H.
    Baboci, L.
    Bertazzo, A.
    Cocco, P.
    Fedato, C.
    Gennaro, M.
    Marchi, N.
    Penon, M. G.
    Cogo, C.
    Ferro, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (10) : 1260 - 1268
  • [46] Should human papillomavirus DNA testing be offered in combination with cytology or as a sole primary screening test in cervical cancer prevention?
    Tristram, Amanda
    FUTURE ONCOLOGY, 2012, 8 (07) : 783 - 786
  • [47] Age patterns of human papillomavirus infection as primary screening test for cervical cancer and subsequent triage with visual inspection in Honduras
    Sandoval, Manuel
    Holme, Francesca
    Lobo, Saul
    Slavkovsky, Rose
    Thomson, Kerry A.
    Jeronimo, Jose
    Figueroa, Jacqueline
    de Sanjose, Silvia
    SALUD PUBLICA DE MEXICO, 2020, 62 (05): : 487 - 493
  • [48] Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening
    Tatar, Ovidiu
    Wade, Kristina
    McBride, Emily
    Thompson, Erika
    Head, Katharine J.
    Perez, Samara
    Shapiro, Gilla K.
    Waller, Jo
    Zimet, Gregory
    Rosberger, Zeev
    JOURNAL OF WOMENS HEALTH, 2020, 29 (03) : 390 - 405
  • [49] Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage
    Yu, Lulu
    Jiang, Mingyue
    Qu, Pengpeng
    Wu, Zeni
    Sun, Peisong
    Xi, Mingrong
    Qin, Yu
    Liu, Xin
    Liao, Guangdong
    Lei, Xiaoqin
    Sun, Lixin
    Zhang, Yongzhen
    Li, Zhifang
    Chen, Wen
    Qiao, You-Lin
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (04) : 813 - 822
  • [50] Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience - Reply
    Agorastos, Theodoros
    GYNECOLOGIC ONCOLOGY, 2006, 103 (03) : 1169 - 1170